SEARCH
A biopharmaceutical company focused on novel immunotherapy agents for cancer and inflammatory diseases.
ABOUT US
HISTORY
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PRODUCTS
OVERVIEW
PIPELINE
CNDO-201
HYGIENE HYPOTHESIS
INFLAMMATORY BOWEL DISEASE
MULTIPLE SCLEROSIS
PUBLISHED CLINICAL TRIALS
CNDO-109
ONCOLOGY THERAPEUTICS MARKET
AML
CLINICAL TRIALS
PUBLICATIONS
PATIENTS
AUTOIMMUNE DISEASES
AML
PATIENT RESOURCES
CLINICAL TRIAL INFORMATION
INVESTORS
STOCK INFORMATION
MANAGEMENT TEAM
BOARD OF DIRECTORS
PRESS RELEASES
EVENTS
SEC FILINGS
CODE OF ETHICS & CORPORATE CHARTER
EMAIL ALERTS
CAREERS
WORKING AT CORONADO
OPEN POSITIONS
CONTACT US
Product Pipeline
Investor Area
Click here for more investor information.
Recent News
January 12, 2012:
Coronado Biosciences to Present at 30th Annual JP Morgan Healthcare Conference
January 6, 2012:
Coronado Biosciences to Present at the Biotech Showcase 2012 Conference
Literature
CNDO-201
Publications
CNDO-109
Publications